In vivo selectively infective phage as a tool to detect protein interactions: evaluation of a novel vector system with yeast Ste7p-Fus3p interacting proteins

Yeast
K HertveldtG Volckaert

Abstract

The selectively infective phage (SIP) approach allows rapid identification of interacting proteins by linking protein-protein interaction to phage infectivity. Infection of E. coli by filamentous phage depends on viral g3p. This protein consists of three domains, N1, N2 and CT. Phages lacking the N1 domain are non-infective unless a bait (X)-prey (Y) interaction links it to phage anchored N2-CT domains. We have developed all the vectors required for an in vivo selectively infective phage strategy (SIP). This includes a bait vector, pG3N1, a prey vector, pHOS41, and a gene III deletion helper phage, HPd3. The bait vector pG3N1 allows expression of a bait protein (X) fused to the C-terminus of the N1 domain. The prey vector pHOS41 allows expression of prey (Y) proteins, fused to the N-terminus of the N2-CT domains. The gene III deletion helper phage delivers all phage proteins necessary for phage production, except g3p. Escherichia coli transformed with these three vectors produces non-infective phages unless a bait-prey interaction links the g3p domains. Fus3p and Ste7p, two proteins from the Saccharomyces cerevisiae pheromone-responsive pathway have been cloned to evaluate the SIP strategy. The presence of the interacting N1-Fu...Continue Reading

References

Nov 30, 1981·FEBS Letters·J ArmstrongJ E Walker
Apr 1, 1995·Trends in Genetics : TIG·W L Tung, K C Chow
Apr 1, 1996·Current Opinion in Cell Biology·R Treisman
Oct 23, 1997·Journal of Bacteriology·E M Click, R E Webster
Oct 29, 1997·Proceedings of the National Academy of Sciences of the United States of America·C GaoK D Janda
Dec 5, 1998·Microbiology and Molecular Biology Reviews : MMBR·M C GustinK Davenport
Mar 20, 1999·Biochemical and Biophysical Research Communications·L L IlagL L Ilag
Jan 29, 2000·Journal of Immunological Methods·S JungA Plückthun
Jun 15, 2000·Proceedings of the National Academy of Sciences of the United States of America·J K JoungC O Pabo

❮ Previous
Next ❯

Citations

Jul 12, 2002·Yeast
Jan 11, 2005·Journal of Biotechnology·T BeliënG Volckaert
Oct 22, 2021·FEMS Microbiology Reviews·Weronika JaroszewiczGrzegorz Węgrzyn

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.